Dallah Healthcare Co. reported a net profit, excluding minority interest, of SAR 82.8 million for Q1 2022, a rise of 59% from SAR 52.2 million in Q1 2021, on higher revenues due to the continued increase in the number of patients along with improved efficiency.
| Item | Q1 2021 | Q1 2022 | Change |
|---|---|---|---|
| Revenues | 494.67 | 609.40 | 23.2 % |
| Gross Income | 176.82 | 231.69 | 31.0 % |
| Operating Income | 72.91 | 109.93 | 50.8 % |
| Net Income | 52.61 | 82.63 | 57.1 % |
| Average Shares | 90.00 | 90.00 | - |
| EPS (Riyals) | 0.58 | 0.92 | 57.1 % |
| Item | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Revenues | 575.57 | 609.40 | 5.9 % |
| Gross Income | 222.91 | 231.69 | 3.9 % |
| Operating Income | 116.48 | 109.93 | (5.6 %) |
| Net Income | 108.60 | 82.63 | (23.9 %) |
| Average Shares | 90.00 | 90.00 | - |
| EPS (Riyals) | 1.21 | 0.92 | (23.9 %) |
Compared to Q4 2021, the net profit, excluding minority interest, edged down 0.8%.
Shareholders’ equity, after minority interest, increased to SAR 1.953 billion as of March 31, 2022, from SAR 1.789 billion a year earlier.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}